Tocilizumab, a monoclonal antibody against IL-6 is used in the treatment of juvenile idiopathic arthritis and autoinflammatory diseases, such as familial Mediterranean fever, cryopyrin-associated periodic syndrome, and tumor necrosis factor receptor-associated periodic syndrome [15]. The gene discussed is IL6; the disease is juvenile idiopathic arthritis.